- Conditions
- Osteoarthritis, Arthropathy, Shoulder Pain, Closed Fracture Proximal Humerus, Four Part
- Interventions
- Liposomal bupivacaine, Interscalene Nerve Block
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 20 Years to 100 Years
- Enrollment
- 108 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 2
- States / cities
- Columbia, Maryland • Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Mar 29, 2020 · Synced May 22, 2026, 3:47 AM EDT